By clicking "Accept" on the Cookie banner, you give us your consent to store and access Cookies and Other Tracking Technologies as described in this Cookie Policy. Accept
About Us Company Profile Milestones Board of Directors Management Team Advisors R & D Pipeline Pulmonary Vascular L606 L608 Peripheral Vascular L608 Technology Sustained Release Inhalation Formulation Drug-Device Combination Scale-up Production Pressroom Press Release Campaigns Videos Publications Investors Corporate Governance Corporate Structure Board of Directors Others Corporate Governance Officer Corporate Governance Implementation ESG (Chinese Only) Information Security Management Intellectual Property Management Integrity management Sustainable Development Stakeholders Financial Information Financial Results Revenues Prospectuses Shareholder Information Annual General Meeting Major Shareholders Stock Affair Agent News & Events Press Releases Events and Presentations Material Information Careers Employee Welfare Environamental Friendliness Job Opening Home 中 EN
放大生產 Zoom in 傳統脂質體劑型與奈米藥物的製備與粒徑控制在實驗室規模的設備下一般不難施行。然而,在商業化量產階段的製程放大生產往往產生許多困難。 國邑藥品的製造團隊在奈米藥物及脂質體劑型,從實驗室開發、製程最佳化研究,製程放大生產從實驗室規模、試製生產到商業化量產,均具有多年豐富經驗。